SCHEMBL8826224

SCHEMBL8826224

Nc1nc(OCc2ccccc2)c2ncn([C@H]3C[C@H](F)[C@@H](CO)O3)c2n1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MGMT P16455 2/20 0.53
▸ ADORA2A P29274 3/20 0.48
▸ ADORA2B P29275 3/20 0.48
▸ SLC29A1 Q99808 4/20 0.48
▸ PNP P00491 1/20 0.44
▸ LMNA P02545 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ PDE4D Q08499 1/20 0.44
▸ PDE3A Q14432 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ NT5E P21589 1/20 0.43
▸ ADORA3 P0DMS8 2/20 0.43
▸ ADORA1 P30542 2/20 0.43
▸ CYP1A2 P05177 1/20 0.41
▸ HBB P68871 1/20 0.41
▸ PDE2A O00408 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6016114 0.90 PNP (0.56) MGMTADORA2AADORA2BSLC29A1PNP
SCHEMBL19631163 0.90 PNP (0.56) MGMTADORA2AADORA2BSLC29A1PNP
SCHEMBL8826156 0.86 SLC29A1 (0.65) ADORA2ASLC29A1TP53ADORA3ADORA1
SCHEMBL8376939 0.85 CYP1A2 (0.43) MGMTADORA2ASLC29A1PNPLMNA
SCHEMBL8939245 0.84 PNP (0.48) ADORA2AADORA2BSLC29A1PNPLMNA
SCHEMBL8830322 0.84 PNP (0.46) ADORA2AADORA2BSLC29A1PNPLMNA
SCHEMBL9360335 0.84 PNP (0.46) ADORA2AADORA2BSLC29A1PNPLMNA
SCHEMBL8826276 0.84 PNP (0.46) ADORA2AADORA2BSLC29A1PNPLMNA
SCHEMBL8826175 0.83 ADORA3 (0.53) ADORA2AADORA2BSLC29A1TP53ADORA3
SCHEMBL8971129 0.81 SLC29A1 (0.62) MGMTADORA2AADORA2BSLC29A1PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663154-A VIRICIDES, HIV, HEPATITIS GLAXO WELLCOME INC. (US) 1997-09-02 — — US claimed
WO-1993014103-A1 THERAPEUTIC NUCLEOSIDES THE WELLCOME FOUNDATION LIMITED (GB) 1993-07-22 — — WO claimed
US-5663154-A VIRICIDES, HIV, HEPATITIS GLAXO WELLCOME INC. (US) 1997-09-02 — — US disclosed
WO-1993014103-A1 THERAPEUTIC NUCLEOSIDES THE WELLCOME FOUNDATION LIMITED (GB) 1993-07-22 — — WO disclosed
Send feedback